CUREVAC N.V. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.67 USD | -0.54% |
|
+11.55% | -12.83% |
| 03:40pm | CureVac, GSK Begin Dosing in Phase 2 Study for Seasonal Influenza Vaccine Candidate | MT |
| May. 23 | CureVac N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bearish |
| Resistance | 3.970 | 6.120 | 5.590 |
| Spread/Res. | -7.56% | -40.03% | -34.35% |
| Spread/Supp. | +17.25% | +58.87% | +57.51% |
| Support | 3.130 | 2.310 | 2.330 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- CVAC Stock
- Charts CureVac N.V.
